Die Prävalenz von Herzklappenerkrankungen in der Allgemeinbevölkerung ist mit ungefähr 2,5% niedrig. Bei den über 75-Jährigen liegt sie mit 10-15% wesentlich höher
document
December 8, 2017 — 00:00
1136
-
-
Se l’incidenza delle valvulopatie è poco rilevante osservando la popolazione in generale, attestandosi al 2,5% circa, fra i pazienti di età superiore a 75 anni la percentuale sale al 10 - 15%.
documentDecember 8, 2017 — 00:00 -
Expert viewsDecember 6, 2017
During her presentation titled “Longevity: recent trends and the role for (re)insurers to meet the challenges” at the SCOR Conference 2017, Daria Ossipova, Head of Health and Longevity R&D at SCOR Global Life, add
-
Presentation of Daria Ossipova about “Longevity: recent trends and the role for (re)insurers to meet the challenges” at the SCOR Annual Conference SCOR.
documentDecember 6, 2017 — 00:00 -
Biography of Daria Ossipova, Head of Health and Longevity R&D at SCOR Global Life
documentDecember 6, 2017 — 00:00 -
Paolo De Martin's presentation at the Pacific Insurance Conference 2017
documentDecember 5, 2017 — 00:00 -
NewsDecember 4, 2017
SCOR is driven to see its clients succeed and puts all its passion and energy into unlocking value for them.
-
Expert viewsNovember 30, 2017
Antimicrobial resistance is a global concern that can jeopardize the treatment of infectious diseases.
-
Although the prevalence of heart valve diseases is low in the general population - around 2.5% - it is much higher in patients aged 75 years and older, reaching 10% to 15%.
documentNovember 17, 2017 — 00:00 -
-
NewsNovember 15, 2017
SCOR Global Life announces the creation of a new Executive Leadership Team.
-
Expert viewsOctober 27, 2017
Breast Cancer Awareness Month is a reminder that breast cancer in women is a real public health issue.
